Biopharmaceutical company

Rubedo Life Sciences is a biopharmaceutical company developing a broad portfolio of
innovative therapies engineered to target cells which drive chronic age-related diseases. Their proprietary ALEMBIC™ drug discovery platform has engineered novel first-in-class small
molecules designed to selectively target various types of senescent cells, which play a key role in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic and other chronic disorders. The Rubedo leadership team is composed of industry leaders and early pioneers in chemistry, technology, and life sciences, with expertise in drug development and commercialization from both large pharma and leading biotech companies. The company is based in Sunnyvale, CA.

https://www.rubedolife.com/

Date of investment April, 2024

Offices Sunnyvale, CA.